New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

The Safe-D study, based in Southampton, Hampshire, is signing up patients with type 2 diabetes, which is a known risk factor ...

Israel and Iran exchange missile attacks for a third day; nuclear sites hit, death tolls rise, airspace shut, U.S. warns ...